A detailed history of Rhumbline Advisers transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 28,720 shares of THRD stock, worth $328,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,720
Previous 28,601 0.42%
Holding current value
$328,844
Previous $371,000 4.85%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.86 - $15.0 $1,292 - $1,785
119 Added 0.42%
28,720 $389,000
Q2 2024

Aug 01, 2024

BUY
$8.74 - $15.54 $69,395 - $123,387
7,940 Added 38.43%
28,601 $371,000
Q1 2024

May 09, 2024

BUY
$8.6 - $11.24 $7,636 - $9,981
888 Added 4.49%
20,661 $195,000
Q4 2023

Feb 08, 2024

BUY
$5.97 - $11.47 $6,835 - $13,133
1,145 Added 6.15%
19,773 $216,000
Q3 2023

Nov 09, 2023

BUY
$4.92 - $7.09 $9,057 - $13,052
1,841 Added 10.97%
18,628 $119,000
Q2 2023

Aug 08, 2023

BUY
$4.18 - $5.33 $20,419 - $26,037
4,885 Added 41.04%
16,787 $80,000
Q1 2023

May 11, 2023

BUY
$3.95 - $4.49 $5,004 - $5,688
1,267 Added 11.91%
11,902 $49,000
Q4 2022

Feb 14, 2023

BUY
$4.0 - $23.97 $42,540 - $254,920
10,635 New
10,635 $46,000

Others Institutions Holding THRD

About Third Harmonic Bio, Inc.


  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $462M
More about THRD
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.